CONTENTS
Issue 92 | March 2020
In association with
What does the next decade have in store for the US opioids crisis?
Is precision medicine any closer to taking on blanket drug development?
Could recyclable unit dose packaging help bolster the green credentials of pharma?
Vertex's Trikafta could be a step in the right direction for cystic fibrosis patients
Talking innovation with the Association for the Cannabinoid Industry
Resistance to anti-fungal medication presents a serious public health risk
Leaks of internal information are the biggest risk facing the life sciences industry
What is behind the sudden shortage of immune globulin?
Turning attention towards patient benefits with IDMP data standards implementation